Adaptive Bio (ADPT) Revenue & Revenue Breakdown
Adaptive Bio Revenue Highlights
Latest Revenue (Y)
$170.28M
Latest Revenue (Q)
$43.19M
Main Segment (Y)
Sequencing Revenue
Main Geography (Y)
Sequencing Revenue
Adaptive Bio Revenue by Period
Adaptive Bio Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $170.28M | -8.11% |
| 2022-12-31 | $185.31M | 20.06% |
| 2021-12-31 | $154.34M | 56.88% |
| 2020-12-31 | $98.38M | 15.65% |
| 2019-12-31 | $85.07M | 52.83% |
| 2018-12-31 | $55.66M | 44.77% |
| 2017-12-31 | $38.45M | - |
Adaptive Bio generated $170.28M in revenue during NA 2023, up -8.11% compared to the previous quarter, and up 305.91% compared to the same period a year ago.
Adaptive Bio Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $43.19M | 3.15% |
| 2024-03-31 | $41.87M | -8.54% |
| 2023-12-31 | $45.78M | 20.74% |
| 2023-09-30 | $37.92M | -22.50% |
| 2023-06-30 | $48.93M | 29.96% |
| 2023-03-31 | $37.65M | -31.80% |
| 2022-12-31 | $55.20M | 15.40% |
| 2022-09-30 | $47.83M | 9.55% |
| 2022-06-30 | $43.66M | 13.05% |
| 2022-03-31 | $38.62M | 1.82% |
| 2021-12-31 | $37.93M | -3.89% |
| 2021-09-30 | $39.47M | 2.50% |
| 2021-06-30 | $38.51M | 0.16% |
| 2021-03-31 | $38.44M | 27.35% |
| 2020-12-31 | $30.18M | 14.78% |
| 2020-09-30 | $26.30M | 25.30% |
| 2020-06-30 | $20.99M | 0.37% |
| 2020-03-31 | $20.91M | -13.63% |
| 2019-12-31 | $24.21M | -7.10% |
| 2019-09-30 | $26.06M | 17.71% |
| 2019-06-30 | $22.14M | 74.78% |
| 2019-03-31 | $12.67M | -26.33% |
| 2018-12-31 | $17.19M | 0.02% |
| 2018-09-30 | $17.19M | 48.58% |
| 2018-06-30 | $11.57M | 19.07% |
| 2018-03-31 | $9.71M | - |
Adaptive Bio generated $43.19M in revenue during Q2 2024, up 3.15% compared to the previous quarter, and up 114.72% compared to the same period a year ago.
Adaptive Bio Revenue Breakdown
Adaptive Bio Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|
| Sequencing Revenue | $78.90M | $41.44M | $43.52M |
| Development Revenue Regulatory Milestones | $10.00M | $2.50M | $2.00M |
| Development Support Revenue | $65.45M | $54.44M | $39.55M |
| Development Revenue | - | $56.94M | $41.55M |
Adaptive Bio's latest annual revenue breakdown by segment (product or service), as of Dec 21: Sequencing Revenue (51.12%), Development Support Revenue (42.40%), and Development Revenue Regulatory Milestones (6.48%).
Quarterly Revenue by Product
| Product/Service | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Medicare Revenue | $500.00K | $1.40M | $500.00K | - | - | - | - | - | - | - | - |
| Sequencing Revenue | - | - | - | $15.17M | $12.71M | $11.28M | $7.99M | $9.47M | $13.89M | $11.68M | $11.87M |
| Development Revenue | - | - | - | $23.27M | $17.48M | $15.02M | $13.00M | $11.44M | - | - | - |
| Sequencing Revenue From Test Deliver | - | - | - | - | - | - | - | - | - | $100.00K | $100.00K |
| Sequencing Revenue From Coverage Policy | - | - | - | - | - | - | - | - | $500.00K | $300.00K | $300.00K |
Adaptive Bio's latest quarterly revenue breakdown by segment (product or service), as of Dec 21: Medicare Revenue (100.00%).
Adaptive Bio Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|
| Sequencing Revenue | $78.90M | $41.44M | $43.52M |
| Development Support Revenue | $65.45M | $54.44M | $39.55M |
| Development Revenue Regulatory Milestones | $10.00M | $2.50M | $2.00M |
| Development Revenue | - | $56.94M | $41.55M |
Adaptive Bio's latest annual revenue breakdown by geography, as of Dec 21: Sequencing Revenue (51.12%), Development Support Revenue (42.40%), and Development Revenue Regulatory Milestones (6.48%).
Quarterly Revenue by Country
| Country | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Medicare Revenue | $500.00K | $1.40M | $500.00K | - | - | - | - | - | - | - | - |
| Development Revenue | - | - | - | $23.27M | $17.48M | $15.02M | $13.00M | $11.44M | - | - | - |
| Sequencing Revenue | - | - | - | $15.17M | $12.71M | $11.28M | $7.99M | $9.47M | $13.89M | $11.68M | $11.87M |
| Sequencing Revenue From Coverage Policy | - | - | - | - | - | - | - | - | $500.00K | $300.00K | $300.00K |
| Sequencing Revenue From Test Deliver | - | - | - | - | - | - | - | - | - | $100.00K | $100.00K |
Adaptive Bio's latest quarterly revenue breakdown by geography, as of Dec 21: Medicare Revenue (100.00%).
Adaptive Bio Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| RPRX | Royalty Pharma | $2.35B | $567.98M |
| BEAM | Beam Therapeutics | $377.71M | $11.77M |
| APLS | Apellis Pharmaceuticals | $366.28M | $179.14M |
| LEGN | Legend Biotech | $285.14M | $93.99M |
| ADPT | Adaptive Bio | $170.28M | $43.19M |
| VIR | Vir Bio | $86.18M | $3.08M |
| KRYS | Krystal Biotech | $50.70M | $70.28M |
| CRBU | Caribou Biosciences | $34.48M | $3.46M |
| VECT | VectivBio | $27.34M | $676.00K |
| VERV | Verve Therapeutics | $11.76M | $5.70M |
| IKNA | Ikena Oncology | $9.16M | - |
| KNTE | Kinnate Biopharma | - | - |
| CWBR | CohBar | - | - |
| AVRO | AVROBIO | - | - |
| ZURA | Zura Bio | - | - |
| ELEV | Elevation Oncology | - | - |
| SANA | Sana Bio | - | - |
| HEPA | Hepion Pharmaceuticals | - | - |
| ENVB | Enveric Biosciences | - | - |
| RPHM | Reneo Pharmaceuticals | - | - |
ADPT Revenue FAQ
What is Adaptive Bio’s yearly revenue?
Adaptive Bio's yearly revenue for 2023 was $170.28M, representing a decrease of -8.11% compared to 2022. The company's yearly revenue for 2022 was $185.31M, representing an increase of 20.06% compared to 2021. ADPT's yearly revenue for 2021 was $154.34M, representing an increase of 56.88% compared to 2020.
What is Adaptive Bio’s quarterly revenue?
Adaptive Bio's quarterly revenue for Q2 2024 was $43.19M, a 3.15% increase from the previous quarter (Q1 2024), and a -11.72% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $41.87M, a -8.54% decrease from the previous quarter (Q4 2023), and a 11.23% increase year-over-year (Q1 2023). ADPT's quarterly revenue for Q4 2023 was $45.78M, a 20.74% increase from the previous quarter (Q3 2023), and a -17.05% decrease year-over-year (Q4 2022).
What is Adaptive Bio’s revenue growth rate?
Adaptive Bio's revenue growth rate for the last 3 years (2021-2023) was 10.32%, and for the last 5 years (2019-2023) was 100.16%.
What are Adaptive Bio’s revenue streams?
Adaptive Bio's revenue streams in c 21 are Sequencing Revenue, Development Revenue Regulatory Milestones, and Development Support Revenue. Sequencing Revenue generated $78.9M in revenue, accounting 51.12% of the company's total revenue, up 90.39% year-over-year. Development Revenue Regulatory Milestones generated $10M in revenue, accounting 6.48% of the company's total revenue, up 300.00% year-over-year. Development Support Revenue generated $65.45M in revenue, accounting 42.40% of the company's total revenue, up 20.21% year-over-year.
What is Adaptive Bio’s main source of revenue?
For the fiscal year ending Dec 21, the largest source of revenue of Adaptive Bio was Sequencing Revenue. This segment made a revenue of $78.9M, representing 51.12% of the company's total revenue.